Clinical and Laboratory Improvement in Hyperadrenergic Postural Orthostatic Tachycardia Syndrome (POTS) after COVID-19 Infection
Keyword(s):
Av Block
◽
A 32-year-old woman with a history of symptomatic supraventricular tachycardia, inappropriate sinus tachycardia, and hyperadrenergic POTS was treated with ivabradine and metoprolol. She then presented with bradycardia and Mobitz II second-degree AV block on event monitoring six weeks after COVID-19 infection. Her post-viral workup revealed normalization of catecholamine levels and significant symptomatic improvement in heart rate. To the authors’ knowledge, this is the first reported case of improvement in POTS after COVID-19 infection. As our understanding of COVID-19 continues to improve, it will be vital to better understand the impact of COVID-19 dysautonomia on cardiac patients.
1998 ◽
Vol 31
(2)
◽
pp. 169A-170A
2009 ◽
Vol 32
(1)
◽
pp. 131-133
◽
1995 ◽
Vol 16
(11)
◽
pp. 1637-1640
◽
1998 ◽
Vol 82
(4)
◽
pp. 531-534
◽
Keyword(s):